Sun Pharma acquires Stada Arzneimittel AG

About The Deal.........

• Acquirer: Sun Pharmaceuticals • Target: Stada Arzneimittel AG• Type of Merger: Horizontal• Buyout: Leveraged Buyout• Value of the Deal: $1 bn(Value of the

enterprise-1.7bn)

About Sun Pharmaceuticals

Stada Arzneimittel AG

• Revenue Break upCore segment(69% of Group sales)Branded Products(28% of Group sales)

Strategic success factors

• Positioning in long-term growth markets• Traditionally strong presence in Europe and continuous

internationalization with a focus on Eastern Europe• Extensive Generics portfolio complemented by high-margin

branded products business• Functionally organized Group with close to market sales

companies• Successful product development with the “time and cheap to

market” strategy• Organic growth complemented by acquisitions with

concentration on high-growth emerging markets and high-margin branded products segment